# SYMBRAVO
> **NDA215431** · New Drug Application · Sponsor: AXSOME · Approved 2025-01-30
## Drug
- **FDA Application Number:** NDA215431
- **Application type:** New Drug Application
- **Brand name:** SYMBRAVO
- **Generic name:** MELOXICAM, RIZATRIPTAN
- **Active ingredients:** MELOXICAM; RIZATRIPTAN BENZOATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AXSOME
- **Manufacturer:** Axsome Therapeutics, Inc.
- **First approval:** 2025-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215431)
---
*AI Analytics · CC0 1.0*